Human milk extracellular vesicles modulate inflammation and cell survival in intestinal and immune cells

Brett Vahkal,Illimar Altosaar,Ardeshir Ariana,Josie Jabbour,Falia Pantieras,Redaet Daniel,Éric Tremblay,Subash Sad,Jean-François Beaulieu,Marceline Côté,Emanuela Ferretti
DOI: https://doi.org/10.1038/s41390-024-03757-5
IF: 3.953
2024-11-30
Pediatric Research
Abstract:Human milk contains extracellular vesicles (EVs) that carry bioactive molecules such as microRNA, to the newborn intestine. The downstream effects of EV cargo on signaling and immune modulation may shield neonates against inflammatory diseases, including necrotizing enterocolitis. Premature infants are especially at risk, while human milk-feeding may offer protection. The effect of gestational-age specific term and preterm EVs from transitional human milk was characterized on human intestinal epithelial cells (HIECs and Caco-2), primary macrophages, and THP-1 monocytes. We hypothesized that term and preterm EVs differentially influence immune-related cytokines and cell death. We found that preterm EVs were enriched in CD14 surface marker, while both term and preterm EVs increased epidermal growth factor secretion. Following inflammatory stimuli, only term EVs inhibited secretion of IL-6 in HIECs, and reduced expression of pro-inflammatory cytokine IL-1β in macrophages. Term and preterm EVs inhibited secretion of IL-1β and reduced inflammasome related cell death. We proposed that human milk EVs regulate immune-related signaling via their conserved microRNA cargo, which could promote tolerance and a homeostatic immune response. These findings provide basis for further studies into potential therapeutic supplementation with EVs in vulnerable newborn populations by considering functional, gestational age-specific effects.
pediatrics
What problem does this paper attempt to address?